Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Cholangiocarcinoma 1Carcinoma, Non-Small-Cell Lung 1Biliary Tract Neoplasms 1

Interventions

Specimen Handling 313Magnetic Resonance Spectroscopy 272pembrolizumab 263Carboplatin 190Cyclophosphamide 177Biopsy 177Cisplatin 165Paclitaxel 137Gemcitabine 137Bevacizumab 122fludarabine 115Nivolumab 114Radiotherapy 111venetoclax 98Oxaliplatin 97Fluorouracil 87Docetaxel 85Dexamethasone 83Capecitabine 83Pemetrexed 76Drug Therapy 76Rituximab 75Leucovorin 71durvalumab 70Radiosurgery 67Doxorubicin 64Blood Specimen Collection 64Standard of Care 63Injections 62atezolizumab 61

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Base Sequence × 90 days × Clear all
NCT05122806 2026-04-29

BIOEXALK

Groupe Francais De Pneumo-Cancerologie

Phase NA Recruiting
100 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06648057 2026-03-18

Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab

CHA University

Recruiting
100 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡